brecanavir

HIV protease inhibitor

Also Known As:

(1S,2R)-3-((1,3-benzodioxol-5-ylsulfonyl)(2-methylpropyl)amino-2-hydroxy-1-((4-(2-methyl-4-thiazolyl)methoxy)phenyl)methylpropyl)carbamic acid, hexahydrofuro(2,3-b)furan-3yl ester; VX-385; VX385

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Acyclic Acids
    - Carbamates: 945
      - brecanavir: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Dioxoles
    - Benzodioxoles: 3
      - brecanavir: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzodioxoles: 3
      - brecanavir: 1

Experts

1.	Anderson, Maggie T: 1 article (04/2007)
2.	Ford, Susan L: 1 article (04/2007)
3.	Johnson, Mark A: 1 article (04/2007)
4.	Murray, Sharon C: 1 article (04/2007)
5.	Ng-Cashin, Judith: 1 article (04/2007)
6.	Reddy, Y Sunila: 1 article (04/2007)

Related Diseases

1.	Infections 04/01/2007 - "Brecanavir (BCV) is a novel, potent protease inhibitor in development for the treatment of human immunodeficiency virus (HIV-1) infection with low nM in vitro 50% inhibitory concentrations (IC50s) against many multiprotease inhibitor resistant viruses. "

Related Drugs and Biologics

1.	Protease Inhibitors (Protease Inhibitor)